GGrantIndex
Sort

23,748 grants matching melanoma

Molecular Analysis of Melanoma Metastasis and Blood in Patients Undergoing Sentin

$726,293
Dave S B Hoon · Saint John'S Cancer Institute · P01 · FY2011 · CA

Leveraging fructose transport to create a privileged substrate to selectively fuel T cells

$726,151
Kayvan R Keshari · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA

Descriptive Studies and Record Linkage

$725,750
William Anderson · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA

PROJECT 2: Development and Refinement of Predictive Models for Designing Immunotherapy Combination Treatments

$725,549
Vesteinn Thorsson · Institute For Systems Biology · U54 · FY2023 · CA

MATCHMAKERS - Creating and training AI tools for TCR binding prediction and design

$725,052
Michael Birnbaum · Massachusetts Institute Of Technology · OT2 · FY2025 · CA

A comparison of interventions to teach patients skin self-examination

$724,343
June K Robinson · Northwestern University At Chicago · R01 · FY2018 · CA

Understanding biomarkers of cognitive decline in Lewy body diseases

$723,980
Alice S Chen-Plotkin · University Of Pennsylvania · R37 · FY2024 · NS

Visualization hub for genomics data exploration and translational discovery

$723,803
Jingchun Zhu · University Of California Santa Cruz · U24 · FY2019 · CA

ID of Molecular Targets for Chemoprevention of Skin Cancer

$723,717
University Of Arizona · P01 · FY2004 · CA

A Stakeholder Informed Randomized Trial of Pretest Video Education vs Standard Genetic Counseling for Cancer Patients: Evaluating the Impact on Patients, Providers and Practices

$723,445
Huma Q Rana · Dana-Farber Cancer Inst · R01 · FY2024 · HG

Project 1: Analysis of cell autonomous mechanisms of phenotypic switching in invasive cancer models

$723,266
Andre Levchenko · Yale University · U54 · FY2020 · CA

Systemic radiotherapy for metastatic melanomas: Innovation of a novel radiopharma

$722,670
James F Kronauge · Molecular Insight Pharmaceuticals, Inc. · R44 · FY2011 · CA

Evaluation of therapeutic efficacy in mouse melenoma models

$722,593
Terry Van Dyke · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Tools to Analyze Morphology and Spatially Mapped Molecular Data

$722,416
Joel H Saltz · State University New York Stony Brook · U24 · FY2015 · CA

Tools to Analyze Morphology and Spatially Mapped Molecular Data

$722,002
Joel H Saltz · State University New York Stony Brook · U24 · FY2017 · CA

Promotion of metastasis by apoptotic cells

$721,836
Andrew Atwell Oberst · University Of Washington · U01 · FY2024 · CA

GCDH Addiction in Melanoma

$721,672
Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2023 · CA

Protein Structure, Stability, and Amyloid Formation

$721,651
Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Biomechanics Of Cochlear Fine Tuning

$721,418
Richard S. Chadwick · National Institute On Deafness And Other Communication Disorders · ZIA · FY2017 · DC

Computational Methods for Identifying Non-coding Cancer Drivers

$721,394
Ekta Khurana · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · CA

PROGRAMMED CELL DEATH 6 INTERACTING PROTEIN (PDCD6IP) IN PLASMA-DERIVED EXOSOMES: A POTENTIAL PROGNOSTIC BIOMARKER OF MELANOMA PROGRESSION

$721,250
University Of Pittsburgh - Of The Commonwealth System Of Higher Education · · FY2022 · Defense Health Agency

Regulation of Metabotropic Glutamate Receptor Signaling

$721,231
Katherine Roche · National Institute Of Neurological Disorders And Stroke · ZIA · FY2012 · NS

Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells

$721,121
Ettore Appella · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy

$721,035
Siddharth Balachandran · Research Inst Of Fox Chase Can Ctr · R01 · FY2024 · CA

Molecular and immunologic evolution of melanomas from pre-neoplastic lesions

$720,975
Boris C Bastian · University Of California, San Francisco · R35 · FY2017 · CA